EDVA
Endovia Health Sciences, Inc.
There isn't enough reported data to score EDVA yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
EDVA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
EDVA's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
EDVA PE Valuation
EDVA has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
EDVA Forward outlook
There aren't enough analyst estimates for EDVA to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
EDVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2024 | -$77.19 | -$1.47 |
| Q1 2024 | -$80.39 | -$0.74 |
| Q4 2023 | -$78.40 | +$12.84 |
| Q3 2021 | -$174.99 | -$154.19 |
| Q2 2021 | -$121.58 | -$107.18 |
| Q1 2021 | -$84.81 | -$70.41 |
| Q4 2020 | -$83.20 | -$76.80 |
| Q3 2020 | -$20.80 | -$19.00 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 202% for EDVA versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
EDVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $4.2K | -99% |
| Q1 2025 | $438.3K | -72% |
| Q4 2024 | $585.9K | -78% |
| Q3 2024 | $981.9K | -81% |
| Q2 2024 | $1M | -80% |
| Q1 2024 | $1.5M | -74% |
| Q4 2023 | $2.7M | -44% |
| Q3 2023 | $5.1M | +5.6% |
UNH has the stronger quarterly revenue trend. Revenue is down 100% for EDVA versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -23176% | -22078 points |
| Q1 2025 | -464% | -253 points |
| Q4 2024 | -1098% | -976 points |
| Q3 2024 | -272% | -188 points |
| Q2 2024 | -353% | -271 points |
| Q1 2024 | -211% | -152 points |
| Q4 2023 | -122% | -23 points |
| Q3 2023 | -84% | +21 points |
EDVA's operating margin was −23176% last quarter, down 22824 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
EDVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.1M | -$411.4K |
| Q1 2026 | -$930.5K | -$206.4K |
| Q2 2025 | -$680.3K | +$1.7M |
| Q1 2025 | -$724.1K | +$583.8K |
| Q3 2024 | -$2.6M | -$663.7K |
| Q2 2024 | -$2.4M | -$9.8K |
| Q1 2024 | -$1.3M | +$2.8M |
| Q4 2023 | -$1.7M | +$1.8M |
EDVA has the stronger cash trend. Its trailing FCF is up 71% versus its history, compared with UNH at up 5.2%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
EDVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.6% | +27K shares |
| 1 year | +17% | +44.1K shares |
| 3 years | +80% | +136K shares |
EDVA has 306,974 diluted shares, up 17% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over EDVA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
EDVA Net Leverage
EDVA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
EDVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 7.9 | Oversold |
EDVA's weekly RSI is 31 (neutral) and its Stochastic is 8 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
EDVA PE vs Healthcare Sector
EDVA has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
EDVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.17 | 5.9% below |
| 20 week MA | $0.30 | 47% below |
| 50 week MA | $1.40 | 89% below |
| 100 week MA | $8.44 | 98% below |
| 200 week MA | $55.4 | 100% below |
EDVA is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over EDVA on trend strength, trading above more of its moving averages.
EDVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $524.8 | $190.4 | -64% |
| 2022 | $190.4 | $135.2 | -29% |
| 2023 | $135.2 | $88.4 | -35% |
| 2024 | $88.4 | $28.0 | -68% |
| 2025 | $28.0 | $3.85 | -86% |
| 2026 YTD | $3.85 | $0.16 | -96% |
EDVA has finished every year since 2021 lower, and it's down 96% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over EDVA on returns for 2026, with the stronger performance.